[Double blind test results on efficacy of the new antivertiginous drug sulpiride (dogmatil) (author's transl)].
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004585:Electrooculography; D006801:Humans; D007273:Injections, Intramuscular; D007759:Labyrinth Diseases / Q000188:drug therapy*; D009759:Nystagmus, Pathologic / Q000188:drug therapy; D010919:Placebos; D013469:Sulpiride / Q000008:administration & dosage / Q000627:therapeutic use*; D014722:Vestibule, Labyrinth / Q000187:drug effects*
D010919:Placebos; D013469:Sulpiride
Ergebnisse einer Doppelblindstudie über die Wirksamkeit des neuen Antivertiginosum Sulpirid (Dogmatil)